Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gitte M Knudsen

Showing results (261-270 of 332) with videos related to

Pageof 34
Sort By:
ACS Chemical Neuroscience|January 19, 2017
Radiosynthesis and Evaluation of [<sup>11</sup>C]3-Hydroxycyclopent-1-enecarboxylic Acid as Potential PET Ligand for the High-Affinity γ-Hydroxybutyric Acid Binding SitesClaus H Jensen, Hanne D Hansen, Tina Bay, et al.
Acta Psychiatrica Scandinavica|February 21, 2025
Relation Between Brain Morphological Features and Psychiatric Hospitalization Risk in Major Depressive and Bipolar DisordersKamilla W Miskowiak, Julian Macoveanu, Brice Ozenne, et al.
Social Cognitive and Affective Neuroscience|March 25, 2017
Violent offenders respond to provocations with high amygdala and striatal reactivitySofi da Cunha-Bang, Patrick M Fisher, Liv Vadskjær Hjordt, et al.
Translational Psychiatry|April 13, 2019
Measuring endogenous changes in serotonergic neurotransmission with [<sup>11</sup>C]Cimbi-36 positron emission tomography in humansSofi da Cunha-Bang, Anders Ettrup, Brenda Mc Mahon, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2012
α4βδ GABA(A) receptors are high-affinity targets for γ-hydroxybutyric acid (GHB)Nathan Absalom, Laura F Eghorn, Inge S Villumsen, et al.
Bipolar Disorders|May 6, 2021
Neuronal underpinnings of cognitive impairment in bipolar disorder: A large data-driven functional magnetic resonance imaging studyJeff Zarp Petersen, Cristina Varo, Cecilie F Skovsen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 28, 2021
Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm studyCheng-Teng Ip, Sebastian Olbrich, Melanie Ganz, et al.
Journal of Psychiatric Research|June 27, 2021
NeuroPharm study: EEG wakefulness regulation as a biomarker in MDDCheng-Teng Ip, Melanie Ganz, Vibeke H Dam, et al.
Journal of Affective Disorders|February 23, 2026
Readiness to change: Exploring clinical, cognitive and neural predictors of treatment efficacy following virtual reality-based cognitive remediation in mood and schizophrenia spectrum disordersAndreas Elleby Jespersen, Laura Montejo, Viktoria Damgaard, et al.
Bipolar Disorders|August 14, 2025
Longitudinal Trajectory of Cognition, Brain Morphometry, and Brain Predicted Age in Unaffected First-Degree Relatives of Patients With Bipolar DisorderHanne Lie Kjærstad, Julian Macoveanu, Alexander Tobias Ysbæk-Nielsen, et al.
Pageof 34

Showing results (261-270 of 332) with videos related to

Sort By:
Pageof 34
ACS Chemical Neuroscience|January 19, 2017
Radiosynthesis and Evaluation of [<sup>11</sup>C]3-Hydroxycyclopent-1-enecarboxylic Acid as Potential PET Ligand for the High-Affinity γ-Hydroxybutyric Acid Binding SitesClaus H Jensen, Hanne D Hansen, Tina Bay, et al.
Acta Psychiatrica Scandinavica|February 21, 2025
Relation Between Brain Morphological Features and Psychiatric Hospitalization Risk in Major Depressive and Bipolar DisordersKamilla W Miskowiak, Julian Macoveanu, Brice Ozenne, et al.
Social Cognitive and Affective Neuroscience|March 25, 2017
Violent offenders respond to provocations with high amygdala and striatal reactivitySofi da Cunha-Bang, Patrick M Fisher, Liv Vadskjær Hjordt, et al.
Translational Psychiatry|April 13, 2019
Measuring endogenous changes in serotonergic neurotransmission with [<sup>11</sup>C]Cimbi-36 positron emission tomography in humansSofi da Cunha-Bang, Anders Ettrup, Brenda Mc Mahon, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2012
α4βδ GABA(A) receptors are high-affinity targets for γ-hydroxybutyric acid (GHB)Nathan Absalom, Laura F Eghorn, Inge S Villumsen, et al.
Bipolar Disorders|May 6, 2021
Neuronal underpinnings of cognitive impairment in bipolar disorder: A large data-driven functional magnetic resonance imaging studyJeff Zarp Petersen, Cristina Varo, Cecilie F Skovsen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 28, 2021
Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm studyCheng-Teng Ip, Sebastian Olbrich, Melanie Ganz, et al.
Journal of Psychiatric Research|June 27, 2021
NeuroPharm study: EEG wakefulness regulation as a biomarker in MDDCheng-Teng Ip, Melanie Ganz, Vibeke H Dam, et al.
Journal of Affective Disorders|February 23, 2026
Readiness to change: Exploring clinical, cognitive and neural predictors of treatment efficacy following virtual reality-based cognitive remediation in mood and schizophrenia spectrum disordersAndreas Elleby Jespersen, Laura Montejo, Viktoria Damgaard, et al.
Bipolar Disorders|August 14, 2025
Longitudinal Trajectory of Cognition, Brain Morphometry, and Brain Predicted Age in Unaffected First-Degree Relatives of Patients With Bipolar DisorderHanne Lie Kjærstad, Julian Macoveanu, Alexander Tobias Ysbæk-Nielsen, et al.
Pageof 34